Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance
Kjobsted, R.; Kristensen, J. M.; Birk, J. B.; Jorgensen, N. O.; Kido, K.; Andersen, N. R.; Larsen, J. K.; Foretz, M.; Benoit, V.; Nielsen, F.; Brosen, K.; Jessen, N.; Hellsten, Y.; Hojlund, K.; Wojtaszewski, J. F. P.
Show abstract
Metformin is an inexpensive oral anti-hyperglycemic agent used worldwide as a first-choice drug for the prevention of type 2 diabetes mellitus (T2DM). Although current view suggests that metformin exerts its anti-hyperglycemic effect by lowering hepatic glucose production, it has been proposed that metformin also reduce hyperglycemia by increasing glucose uptake in skeletal muscle via activation of AMP-activated protein kinase (AMPK). Herein, we demonstrate in lean and diet-induced obese (DIO) male and female mouse models that the anti-hyperglycemic effect of metformin occurs independently of muscle AMPK, and instead relies on elevated intestinal glucose clearance. Furthermore, we report that the AMPK activity is elevated in skeletal muscle from patients with T2DM following chronic metformin treatment, but this is not associated with enhanced peripheral insulin sensitivity. These results argue against existing paradigms and emphasize the non-essential role of muscle AMPK but important role of the intestine for the anti-hyperglycemic effect of metformin.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The effects of caloric restriction on adipose tissue and metabolic health are sex- and age-dependent 95%
- Targeting IRE1alpha improves insulin sensitivity and thermogenesis and suppresses metabolically active adipose tissue macrophages in male obese mice 95%
- Control of brown adipose tissue adaptation to nutrient stress by the activin receptor ALK7 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant. 96%
- Active integrins regulate white adipose tissue insulin sensitivity and brown fat thermogenesis 96%
- Hepatic Mitochondrial Remodeling is Mechanistically Linked to Insulin Resistance in Nonalcoholic Fatty Liver Disease 95%
Similar papers in this journal
- Bromodomain inhibition reveals FGF15/19 as a target of epigenetic regulation and metabolic control 96%
- Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity 96%
- Increased energy expenditure and protection from diet-induced obesity in mice lacking the cGMP-specific phosphodiesterase, PDE9 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.